Divergent roles of Plexin D1 in cancer

Sneha Vivekanadhan, Debabrata Mukhopadhyay

Research output: Contribution to journalReview article

Abstract

Plexin D1 belongs to a family of transmembrane proteins called plexins. It was characterized as a receptor for semaphorins and is known to be essential for axonal guidance and vascular patterning. Mutations in Plexin D1 have been implicated in pathologic conditions such as truncus arteriosus and Möbius syndrome. Emerging data show that expression of Plexin D1 is deregulated in several cancers; it can support tumor development by aiding in tumor metastasis and EMT; and conversely, it can act as a dependence receptor and stimulate cell death in the absence of its canonical ligand, semaphorin 3E. The role of Plexin D1 in tumor development and progression is thereby garnering research interest for its potential as a biomarker and as a therapeutic target. In this review, we describe its discovery, structure, mutations, role(s) in cancer, and therapeutic potential.

Original languageEnglish (US)
Pages (from-to)103-110
Number of pages8
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1872
Issue number1
DOIs
StatePublished - Aug 1 2019

Fingerprint

Semaphorins
Neoplasms
Truncus Arteriosus
Mutation
Blood Vessels
Cell Death
Biomarkers
plexin
Neoplasm Metastasis
Ligands
Therapeutics
Research
Proteins

Keywords

  • Angiogenesis
  • Cancer
  • Metastasis
  • Plexin
  • Plexin D1

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Divergent roles of Plexin D1 in cancer. / Vivekanadhan, Sneha; Mukhopadhyay, Debabrata.

In: Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1872, No. 1, 01.08.2019, p. 103-110.

Research output: Contribution to journalReview article

@article{73325cb05ea8463a8f41b06f271dd5b5,
title = "Divergent roles of Plexin D1 in cancer",
abstract = "Plexin D1 belongs to a family of transmembrane proteins called plexins. It was characterized as a receptor for semaphorins and is known to be essential for axonal guidance and vascular patterning. Mutations in Plexin D1 have been implicated in pathologic conditions such as truncus arteriosus and M{\"o}bius syndrome. Emerging data show that expression of Plexin D1 is deregulated in several cancers; it can support tumor development by aiding in tumor metastasis and EMT; and conversely, it can act as a dependence receptor and stimulate cell death in the absence of its canonical ligand, semaphorin 3E. The role of Plexin D1 in tumor development and progression is thereby garnering research interest for its potential as a biomarker and as a therapeutic target. In this review, we describe its discovery, structure, mutations, role(s) in cancer, and therapeutic potential.",
keywords = "Angiogenesis, Cancer, Metastasis, Plexin, Plexin D1",
author = "Sneha Vivekanadhan and Debabrata Mukhopadhyay",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.bbcan.2019.05.004",
language = "English (US)",
volume = "1872",
pages = "103--110",
journal = "Biochimica et Biophysica Acta - Reviews on Cancer",
issn = "0304-419X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Divergent roles of Plexin D1 in cancer

AU - Vivekanadhan, Sneha

AU - Mukhopadhyay, Debabrata

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Plexin D1 belongs to a family of transmembrane proteins called plexins. It was characterized as a receptor for semaphorins and is known to be essential for axonal guidance and vascular patterning. Mutations in Plexin D1 have been implicated in pathologic conditions such as truncus arteriosus and Möbius syndrome. Emerging data show that expression of Plexin D1 is deregulated in several cancers; it can support tumor development by aiding in tumor metastasis and EMT; and conversely, it can act as a dependence receptor and stimulate cell death in the absence of its canonical ligand, semaphorin 3E. The role of Plexin D1 in tumor development and progression is thereby garnering research interest for its potential as a biomarker and as a therapeutic target. In this review, we describe its discovery, structure, mutations, role(s) in cancer, and therapeutic potential.

AB - Plexin D1 belongs to a family of transmembrane proteins called plexins. It was characterized as a receptor for semaphorins and is known to be essential for axonal guidance and vascular patterning. Mutations in Plexin D1 have been implicated in pathologic conditions such as truncus arteriosus and Möbius syndrome. Emerging data show that expression of Plexin D1 is deregulated in several cancers; it can support tumor development by aiding in tumor metastasis and EMT; and conversely, it can act as a dependence receptor and stimulate cell death in the absence of its canonical ligand, semaphorin 3E. The role of Plexin D1 in tumor development and progression is thereby garnering research interest for its potential as a biomarker and as a therapeutic target. In this review, we describe its discovery, structure, mutations, role(s) in cancer, and therapeutic potential.

KW - Angiogenesis

KW - Cancer

KW - Metastasis

KW - Plexin

KW - Plexin D1

UR - http://www.scopus.com/inward/record.url?scp=85067567623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067567623&partnerID=8YFLogxK

U2 - 10.1016/j.bbcan.2019.05.004

DO - 10.1016/j.bbcan.2019.05.004

M3 - Review article

VL - 1872

SP - 103

EP - 110

JO - Biochimica et Biophysica Acta - Reviews on Cancer

JF - Biochimica et Biophysica Acta - Reviews on Cancer

SN - 0304-419X

IS - 1

ER -